Sodium nitroprusside
Sodium nitroprusside (SNP), sold under the brand name Nitropress among others, is a medication used to lower blood pressure. This may be done if the blood pressure is very high and resulting in symptoms, in certain types of heart failure, and during surgery to decrease bleeding. It is used by continuous injection into a vein. Onset is nearly immediate and effects last for up to ten minutes.
Molecular structure of this compound (top), and a picture of a sample (bottom). | |
Clinical data | |
---|---|
Trade names | Nipride, Nitropress, others |
Other names | SNP |
AHFS/Drugs.com | Monograph |
License data |
|
Pregnancy category |
|
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 100% (intravenous) |
Metabolism | By haemoglobin being converted to cyanmethaemoglobin and cyanide ions |
Onset of action | nearly immediate |
Elimination half-life | <2 minutes (3 days for thiocyanate metabolite) |
Duration of action | 1 to 10 minutes |
Excretion | kidney (100%; as thiocyanate) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.119.126 |
Chemical and physical data | |
Formula | C5FeN6Na2O |
Molar mass | 261.921 g·mol−1 |
3D model (JSmol) | |
Density | 1.72 g/cm3 |
Solubility in water | 100 mg/mL (20 °C) |
| |
|
It is available as a generic medication.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.